RE: ValJu. IMO20 Nov 2019 11:26
ValJu, I mentioned on here few times, I personally wrote off 401, it was a bonus if it come any good and even now I still think the same, I said it was a bonus if the compound was interested. It is fine if the compound doesn't come good, we should prepare for that as it is normal in research. Our real anger is about their bad management and why it takes so long to get and details about 201.
Obviously Val took on 401 with the hope they would make good of the compound and profit and their intention was to complete phase 2. No way Val has money to take it any further, the company is on its knee, and if you are here long enough then you would realise that Val, financially, was doing OK before Val201 clinical trials and it was worst when they took on Val401. Now, why we still don't get any report on the six parties then we should ask the person in charge.